Hudson Valley Investment Advisors Inc Abbott Laboratories Transaction History

Hudson Valley Investment Advisors Inc

$813 Million
Q2 2024

A detailed history of Hudson Valley Investment Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Hudson Valley Investment Advisors Inc holds 10,819 shares of ABT stock, worth $1.21 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

10,819

Previous 10,819 -0.0%

Holding current value

$1.21 Million

Previous $1.23 Million 8.54%

% of portfolio

0.14%

Previous 0.15%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$90.19 - $110.4 $57,451 - $70,324	-637 Reduced 5.56%	10,819 $1.19 Million
Q3 2023 Oct 27, 2023	SELL	$95.53 - $114.62 $7,164 - $8,596	-75 Reduced 0.65%	11,456 $1.11 Million
Q2 2023 Jul 17, 2023	SELL	$100.78 - $112.29 $24,791 - $27,623	-246 Reduced 2.09%	11,531 $1.26 Million
Q1 2023 Apr 06, 2023	SELL	$96.86 - $114.01 $31,479 - $37,053	-325 Reduced 2.69%	11,777 $1.19 Million
Q4 2022 Jan 31, 2023	SELL	$95.06 - $111.52 $9,506 - $11,152	-100 Reduced 0.82%	12,102 $1.33 Million
Q3 2022 Oct 11, 2022	SELL	$96.76 - $112.03 $20,222 - $23,414	-209 Reduced 1.68%	12,202 $1.18 Million
Q2 2022 Jul 18, 2022	BUY	$102.07 - $123.37 $21,740 - $26,277	213 Added 1.75%	12,411 $1.35 Million
Q3 2021 Oct 26, 2021	SELL	$116.66 - $129.06 $197,272 - $218,240	-1,691 Reduced 12.18%	12,198 $1.44 Million
Q2 2021 Jul 07, 2021	SELL	$105.79 - $124.53 $79,765 - $93,895	-754 Reduced 5.15%	13,889 $1.61 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $24,489 - $28,851	-225 Reduced 1.51%	14,643 $1.76 Million
Q4 2020 Jan 15, 2021	SELL	$105.0 - $114.42 $45,675 - $49,772	-435 Reduced 2.84%	14,868 $1.63 Million
Q3 2020 Oct 13, 2020	SELL	$91.64 - $111.29 $169,075 - $205,330	-1,845 Reduced 10.76%	15,303 $1.67 Million
Q2 2020 Jul 07, 2020	SELL	$76.57 - $98.0 $103,369 - $132,300	-1,350 Reduced 7.3%	17,148 $1.57 Million
Q1 2020 Apr 29, 2020	SELL	$62.82 - $91.86 $185,507 - $271,262	-2,953 Reduced 13.77%	18,498 $1.46 Million
Q2 2019 Jul 16, 2019	SELL	$72.88 - $85.0 $3,644 - $4,250	-50 Reduced 0.23%	21,451 $1.8 Million
Q1 2019 Apr 10, 2019	SELL	$66.22 - $80.06 $104,296 - $126,094	-1,575 Reduced 6.83%	21,501 $1.72 Million
Q4 2018 Jan 17, 2019	BUY	$65.56 - $74.27 $13,112 - $14,854	200 Added 0.87%	23,076 $1.67 Million
Q2 2018 Jul 10, 2018	SELL	$57.57 - $63.54 $72,653 - $80,187	-1,262 Reduced 5.23%	22,876 $1.4 Million
Q1 2018 Apr 12, 2018	BUY	$56.27 - $63.62 $4,220 - $4,771	75 Added 0.31%	24,138 $1.45 Million
Q4 2017 Jan 16, 2018	SELL	$53.68 - $57.47 $13,956 - $14,942	-260 Reduced 1.07%	24,063 $1.37 Million
Q3 2017 Oct 13, 2017	BUY	$48.06 - $53.64 $1.17 Million - $1.3 Million	24,323	24,323 $1.3 Million

Others Institutions Holding ABT

# of Institutions

3,138

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Valley Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hudson Valley Investment Advisors Inc with notifications on news.

Account

Hudson Valley Investment Advisors Inc Abbott Laboratories Transaction History